SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-004249
Filing Date
2019-05-07
Accepted
2019-05-07 16:07:32
Documents
67
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-20190331x10q.htm 10-Q 1983365
2 EX-10.1 ardx-20190331ex101320fc2.htm EX-10.1 28198
3 EX-31.1 ardx-20190331ex311df81b8.htm EX-31.1 22349
4 EX-31.2 ardx-20190331ex312f289bd.htm EX-31.2 22328
5 EX-32.1 ardx-20190331ex321da068b.htm EX-32.1 16856
  Complete submission text file 0001558370-19-004249.txt   7195830

Data Files

Seq Description Document Type Size
6 EX-101.INS ardx-20190331.xml EX-101.INS 1652530
7 EX-101.SCH ardx-20190331.xsd EX-101.SCH 44498
8 EX-101.CAL ardx-20190331_cal.xml EX-101.CAL 58127
9 EX-101.DEF ardx-20190331_def.xml EX-101.DEF 168322
10 EX-101.LAB ardx-20190331_lab.xml EX-101.LAB 334242
11 EX-101.PRE ardx-20190331_pre.xml EX-101.PRE 304021
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 19803134
SIC: 2834 Pharmaceutical Preparations